PLUS1
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Johnson and Johnson | NYSE:JNJ | NYSE | Common Stock |
| Price Change | % Change | Share Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|
| -0.7119 | -0.49% | 143.2581 | 1,200,111 | 15:00:17 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 144.29 | 143.17 | 143.74 | |||
| Industry Sector | Turnover (m) | Profit (m) | EPS - Basic | PE Ratio | Market Cap (m) |
|---|---|---|---|---|---|
| Healthcare | 82,059.00 | 17,240.60 | 5.63 | 22.8 | 377,173 |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 15:00:17 | 65 | 143.28 | USD |
Johnson and Johnson (JNJ) Latest News
Johnson and Johnson News
| Date | Time | Source | Headline |
|---|---|---|---|
| 23/10/2020 | 22:18 | DJN | Pivotal Studies of Covid-19 Vaccines From AstraZeneca, J&J Resuming -- 3rd.. |
| 23/10/2020 | 21:13 | DJN | Pivotal Study of J&J's Covid-19 Vaccine to Resume, Company Says |
| 22/10/2020 | 09:59 | DJN | Covid-19 Vaccine Makers to Face Challenges When Recognizing Revenue |
| 16/10/2020 | 12:36 | DJN | J&J's Janssen Gets CHMP Positive Opinion for Tremfya in Active Psoriatic.. |
| 16/10/2020 | 11:59 | DJN | NIH to Study Three Drugs in Treatment of Covid-19 Patients |
| 13/10/2020 | 21:10 | DJN | Companies Grapple With Sustainability Data -- Journal Report |
| 13/10/2020 | 18:07 | DJN | J&J Hopes Covid-19 Vaccine Trial Will Restart Shortly |
| 13/10/2020 | 11:35 | DJN | Johnson & Johnson Boosts Full-Year Forecast |
| 13/10/2020 | 11:29 | DJN | Johnson & Johnson Reports Gains in 3Q Profit, Revenue |
| 13/10/2020 | 11:25 | DJN | J&J Vaccine Pause Shows Challenges Still Ahead for Covid-19 Shots |
Johnson and Johnson (JNJ) Share Charts1 Year Johnson and Johnson Chart |
|
1 Month Johnson and Johnson Chart |
Intraday Johnson and Johnson Chart |
